| Robert C Osburne, MD | |
|
850 Peter Bryce Blvd, Tuscaloosa, AL 35401-7457 | |
| (205) 873-2699 | |
| Not Available |
| Full Name | Robert C Osburne |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 50 Years |
| Location | 850 Peter Bryce Blvd, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740289925 | NPI | - | NPPES |
| 134091 | Medicaid | AL | |
| 000890095 A,B | Medicaid | GA | |
| 511-19472 | Other | AL | BCBS OF AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 10201 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capstone Health Services Foundation Pc | 6103724489 | 120 |
News Archive
Advanced Biological Laboratories (ABL) S.A., a Luxembourg-based company today announced that it has entered into an exclusive worldwide licensing agreement with CRP-Santé, a Luxembourg-based public research center active in the field of clinically oriented biomedical research, for its COMET (COntext-based Modeling for Expeditious Typing) software, a tool designed to rapidly analyze and optimally subtype large genetic data sets arising from epidemiological or antiretroviral resistance in the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) fields.
It may be that IQ tests are not the only way to measure human intelligence. Scientists at The Queensland Institute of Medical Science (QIMR) have identified two regions of the human genome that appear to explain variation in IQ. Their work was published this week in the American Journal of Human Genetics and has drawn world-wide interest.
Labopharm Inc. today announced that Hercules Technology Growth Capital, Inc. has agreed to amend Labopharm's debt facility agreement such that Hercules has extended both the period of interest-only payments on the loan and the maturity date of the loan. The amended agreement provides Labopharm with approximately $4.5 million in additional liquidity in 2010 and throughout 2011.
A new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) shows that RNA nanoparticles have elastic and rubbery properties that help explain why these particles target tumors so efficiently and why they possess lower toxicity in animal studies.
› Verified 7 days ago
| Entity Name | Capstone Health Services Foundation Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740397751 PECOS PAC ID: 6103724489 Enrollment ID: O20040330001160 |
News Archive
Advanced Biological Laboratories (ABL) S.A., a Luxembourg-based company today announced that it has entered into an exclusive worldwide licensing agreement with CRP-Santé, a Luxembourg-based public research center active in the field of clinically oriented biomedical research, for its COMET (COntext-based Modeling for Expeditious Typing) software, a tool designed to rapidly analyze and optimally subtype large genetic data sets arising from epidemiological or antiretroviral resistance in the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) fields.
It may be that IQ tests are not the only way to measure human intelligence. Scientists at The Queensland Institute of Medical Science (QIMR) have identified two regions of the human genome that appear to explain variation in IQ. Their work was published this week in the American Journal of Human Genetics and has drawn world-wide interest.
Labopharm Inc. today announced that Hercules Technology Growth Capital, Inc. has agreed to amend Labopharm's debt facility agreement such that Hercules has extended both the period of interest-only payments on the loan and the maturity date of the loan. The amended agreement provides Labopharm with approximately $4.5 million in additional liquidity in 2010 and throughout 2011.
A new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) shows that RNA nanoparticles have elastic and rubbery properties that help explain why these particles target tumors so efficiently and why they possess lower toxicity in animal studies.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert C Osburne, MD 850 Peter Bryce Blvd, Tuscaloosa, AL 35401-7457 Ph: (205) 348-1770 | Robert C Osburne, MD 850 Peter Bryce Blvd, Tuscaloosa, AL 35401-7457 Ph: (205) 873-2699 |
News Archive
Advanced Biological Laboratories (ABL) S.A., a Luxembourg-based company today announced that it has entered into an exclusive worldwide licensing agreement with CRP-Santé, a Luxembourg-based public research center active in the field of clinically oriented biomedical research, for its COMET (COntext-based Modeling for Expeditious Typing) software, a tool designed to rapidly analyze and optimally subtype large genetic data sets arising from epidemiological or antiretroviral resistance in the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) fields.
It may be that IQ tests are not the only way to measure human intelligence. Scientists at The Queensland Institute of Medical Science (QIMR) have identified two regions of the human genome that appear to explain variation in IQ. Their work was published this week in the American Journal of Human Genetics and has drawn world-wide interest.
Labopharm Inc. today announced that Hercules Technology Growth Capital, Inc. has agreed to amend Labopharm's debt facility agreement such that Hercules has extended both the period of interest-only payments on the loan and the maturity date of the loan. The amended agreement provides Labopharm with approximately $4.5 million in additional liquidity in 2010 and throughout 2011.
A new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) shows that RNA nanoparticles have elastic and rubbery properties that help explain why these particles target tumors so efficiently and why they possess lower toxicity in animal studies.
› Verified 7 days ago
Robert Pieroni, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 850 5th Ave E, Tuscaloosa, AL 35401 Phone: 205-348-1770 Fax: 205-348-5353 | |
Dr. Mark Bruce Nissenbaum, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3701 Loop Rd, Va Medical Center (679/11), Tuscaloosa, AL 35404 Phone: 205-554-2000 Fax: 205-554-2034 | |
Dr. Kyathanahally M. Dinesh Chandra, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 701 University Blvd E, Suite 711, Tuscaloosa, AL 35401 Phone: 205-345-2255 | |
John Warren, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1100 Ruby Tyler Pkwy, Tuscaloosa, AL 35404 Phone: 205-759-2582 Fax: 205-759-2985 | |
Dr. Neil Kirit Shah, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 850 Peter Bryce Blvd, Tuscaloosa, AL 35401 Phone: 205-348-1770 Fax: 205-348-5145 | |
Bassam Mushannen, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1060 Fairfax Park, Ste B, Tuscaloosa, AL 35406 Phone: 205-758-6471 Fax: 205-758-6472 | |
Michael Shortall, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3701 Loop Rd, Tuscaloosa, AL 35404 Phone: 205-554-2000 Fax: 205-554-2824 |